2M BioTech (Claria Bioscience)
Melissa Krauth
PrincipalAbbVie
Kevin Lynch
Vice President Search and Evaluation
Advent Life Sciences
Advent Life Sciences
We invest predominantly in early and mid-stage life sciences companies. We seek to back truly innovative companies that have a first-in-class or best-in-class approach and who are looking for a well-connected partner on the road to success.
Our investments cover a range of sectors within life sciences, including new drug discovery, enabling technologies, med tech and diagnostics.Advent Life Sciences is one of Europe’s leading venture teams investing in life sciences businesses. We are a deliberately small, and highly focused team of senior individuals, with long-standing track records of entrepreneurial and investment success across the UK, Europe and the USA.
Real people. Real insight. Real value.
Innovation. Clarity. Execution.
AFH Holding & Advisory
Amir Heshmatpour
Founder & Managing DirectorAisling Capital
Dennis Purcell
Founder and Senior AdvisorAlexion
Mark Day
Senior Director Strategic Evaluation
Antibody Solutions
Antibody Solutions is a premier developer of therapeutic, diagnostic and critical reagent antibodies. Our platforms include human antibodies from transgenic OmniRats™, Hybridoma Libraries™, and high-throughput flow-cytometry screening of cell-associated targets. We provide full technical support and project management with all services performed in the USA.
John Kenney
PresidentApple Tree Partners
Apple Tree Partners is a private equity fund that was established in 1999 and based in New York, NY, with satellite offices in Princeton, NJ, Cambridge, MA and Brussels, Belgium. The firm controls up to $1.75 billion in assets under management and makes equity investments ranging from $100,000 for academic spinouts to $150 million dollar in later stage deals. The firm seeks to make investments around the globe with a focus on creating and building companies located within the US and Europe.